UK markets closed
NIKKEI 225
38,556.87 -298.50 (-0.77%) HANG SENG
18,477.01 -344.15 (-1.83%) CRUDE OIL
79.08 -0.75 (-0.94%) GOLD FUTURES
2,337.70 -18.80 (-0.80%) DOW
38,461.96 -390.90 (-1.01%) Bitcoin GBP
53,046.45 -540.66 (-1.01%)
Rigel Pharmaceuticals, Inc. (RIGL)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 03:04PM EDT. Market open.
| Previous close | 0.9314 |
| Open | 0.9300 |
| Bid | 0.9156 x 700 |
| Ask | 0.9263 x 100 |
| Day's range | 0.9101 - 0.9337 |
| 52-week range | 0.7100 - 1.7700 |
| Volume | |
| Avg. volume | 1,530,601 |
| Market cap | 161.549M |
| Beta (5Y monthly) | 1.05 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Rigel (RIGL) Upgraded to Buy: Here's What You Should Know
Rigel (RIGL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
- Simply Wall St.
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Analysts Are Pretty Bullish On The Stock After Recent Results
The analysts might have been a bit too bullish on Rigel Pharmaceuticals, Inc. ( NASDAQ:RIGL ), given that the company...
- Insider Monkey
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q1 2024 Earnings Call Transcript
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q1 2024 Earnings Call Transcript May 7, 2024 Rigel Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings and welcome to Rigel Pharmaceuticals Financial Conference Call for the First Quarter 2024. At this time, […]
© 2024 Yahoo. All rights reserved.